Investment
Features
FeesSafety
Academy
More
Pluang+

Starknet launches Shadow Accounts to boost DeFi wallet privacy by separating app activity from main wallets.

Protocol Fundamentals
14 Oct 2026
Blockonomi
View Source
Bullish
Starknet launches Shadow Accounts to boost DeFi wallet privacy by separating app activity from main wallets.

Starknet, a layer-2 Ethereum network, introduced Shadow Accounts, a new privacy feature allowing users to separate their DeFi app activities from their main wallets. These persistent, app-specific addresses are funded from a shared privacy pool, hiding the link to the main wallet while keeping transactions and balances visible onchain. This feature enhances user privacy without full anonymity and may expand to lending, staking, derivatives, and NFT marketplaces. It builds on StarkWare's earlier privacy tools like the STRK20 framework and Private KYC system, marking a significant step in decentralized finance privacy.

Starknet's launch of Shadow Accounts for private DeFi activity is presented here with a snapshot of the broader cryptocurrency market on Pluang. As of Oct 14, 2026 16:31 WIB, 13 out of 50 major cryptocurrencies rose while 36 fell. Kusama (KSM) traded at Rp82.978 with a 3.24% decline and a typical hold time of 80 days, while MultiversX (EGLD) was priced at Rp66.905 with a 3.09% drop and 100% buy order activity on Pluang.

More News

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...

Others
Bullish
1 hour ago
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
Bullish
2 hours ago
FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
Bullish
2 hours ago
DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...

Company Fundamentals
Neutral
2 hours ago
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App